STOCK TITAN

[Form 4] Medical Properties Trust, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Medical Properties Trust, Inc. (MPW) – Form 4 filing, 8 Jul 2025

Chairman, President & CEO Edward K. Aldag Jr. reported a routine, non-open-market transaction coded “F,” indicating tax withholding on the vesting of restricted stock. The company withheld 117,161 common shares at an implied price of $4.35 per share to cover statutory taxes. After the withholding, Aldag continues to directly own 5,354,656 MPW shares. No derivative securities were involved, and there were no open-market purchases or sales. The filing does not signal a change in Aldag’s overall ownership strategy or the company’s fundamentals.

  • Transaction type: Code F (tax withholding, not a voluntary sale)
  • Shares withheld: 117,161 (≈2.2 % of Aldag’s post-transaction holdings)
  • Remaining direct holdings: 5,354,656 shares
  • No new options, warrants, or derivatives disclosed

The action is administrative and generally viewed as neutral from a market-impact perspective.

Medical Properties Trust, Inc. (MPW) – Comunicazione Form 4, 8 luglio 2025

Il Presidente, Amministratore Delegato ed Executive Chairman Edward K. Aldag Jr. ha riportato una transazione di routine, non effettuata sul mercato aperto, contrassegnata con il codice “F”, che indica il ritenuta fiscale sulla maturazione di azioni vincolate. La società ha trattenuto 117.161 azioni ordinarie a un prezzo implicito di 4,35 $ per azione per coprire le imposte dovute. Dopo questa ritenuta, Aldag detiene direttamente ancora 5.354.656 azioni MPW. Non sono stati coinvolti strumenti derivati e non ci sono stati acquisti o vendite sul mercato aperto. La comunicazione non indica cambiamenti nella strategia complessiva di possesso di Aldag né nei fondamentali della società.

  • Tipo di transazione: Codice F (ritenuta fiscale, non vendita volontaria)
  • Azioni trattenute: 117.161 (circa il 2,2% delle partecipazioni di Aldag dopo la transazione)
  • Detenzioni dirette residue: 5.354.656 azioni
  • Nessuna nuova opzione, warrant o derivato dichiarato

L’operazione è di natura amministrativa ed è generalmente considerata neutrale in termini di impatto sul mercato.

Medical Properties Trust, Inc. (MPW) – Presentación Formulario 4, 8 de julio de 2025

El Presidente, Director General y CEO Edward K. Aldag Jr. reportó una transacción rutinaria, no realizada en el mercado abierto, codificada como “F”, que indica retención fiscal sobre la consolidación de acciones restringidas. La empresa retuvo 117,161 acciones comunes a un precio implícito de $4.35 por acción para cubrir los impuestos legales. Tras la retención, Aldag continúa poseyendo directamente 5,354,656 acciones de MPW. No se involucraron valores derivados, ni hubo compras o ventas en el mercado abierto. La presentación no señala un cambio en la estrategia general de propiedad de Aldag ni en los fundamentos de la empresa.

  • Tipo de transacción: Código F (retención fiscal, no venta voluntaria)
  • Acciones retenidas: 117,161 (≈2.2 % de las participaciones de Aldag tras la transacción)
  • Participaciones directas restantes: 5,354,656 acciones
  • No se revelaron nuevas opciones, warrants ni derivados

La acción es de carácter administrativo y generalmente se considera neutral en cuanto a su impacto en el mercado.

Medical Properties Trust, Inc. (MPW) – 2025년 7월 8일 Form 4 제출

회장 겸 사장 및 CEO인 Edward K. Aldag Jr.는 “F” 코드로 분류된 일상적인 비공개시장 거래를 보고했으며, 이는 제한 주식의 취득에 따른 세금 원천징수를 의미합니다. 회사는 법정 세금을 충당하기 위해 주당 4.35달러의 암시 가격으로 117,161 보통주를 원천징수했습니다. 원천징수 후 Aldag는 직접적으로 5,354,656 MPW 주식을 계속 보유하고 있습니다. 파생 증권은 포함되지 않았으며, 공개 시장에서의 매매도 없었습니다. 이번 제출은 Aldag의 전체 보유 전략이나 회사의 기본적 상황에 변화를 의미하지 않습니다.

  • 거래 유형: 코드 F (세금 원천징수, 자발적 매도가 아님)
  • 원천징수된 주식 수: 117,161주 (거래 후 Aldag 보유 주식의 약 2.2%)
  • 남은 직접 보유 주식: 5,354,656주
  • 새로운 옵션, 워런트 또는 파생상품 없음

이번 조치는 행정적인 성격이며 시장 영향 측면에서 중립적으로 평가됩니다.

Medical Properties Trust, Inc. (MPW) – Déclaration Formulaire 4, 8 juillet 2025

Le Président, Directeur Général et CEO Edward K. Aldag Jr. a signalé une transaction de routine, non réalisée sur le marché ouvert, codée « F », indiquant une retenue fiscale sur l’acquisition d’actions restreintes. La société a retenu 117 161 actions ordinaires à un prix implicite de 4,35 $ par action pour couvrir les impôts légaux. Après cette retenue, Aldag détient directement 5 354 656 actions MPW. Aucun titre dérivé n’a été impliqué, et aucune opération sur le marché ouvert n’a eu lieu. Cette déclaration ne traduit aucun changement dans la stratégie globale de détention d’Aldag ni dans les fondamentaux de la société.

  • Type de transaction : Code F (retenue fiscale, pas une vente volontaire)
  • Actions retenues : 117 161 (environ 2,2 % des avoirs d’Aldag après la transaction)
  • Actions détenues directement restantes : 5 354 656
  • Aucune nouvelle option, warrant ou dérivé déclaré

L’opération est de nature administrative et est généralement considérée comme neutre en termes d’impact sur le marché.

Medical Properties Trust, Inc. (MPW) – Form 4 Einreichung, 8. Juli 2025

Der Vorsitzende, Präsident und CEO Edward K. Aldag Jr. meldete eine routinemäßige, nicht am offenen Markt durchgeführte Transaktion mit dem Code „F“, was auf eine steuerliche Einbehaltung bei der Freigabe von eingeschränkten Aktien hinweist. Das Unternehmen behielt 117.161 Stammaktien zu einem impliziten Preis von 4,35 $ pro Aktie ein, um die gesetzlichen Steuern zu decken. Nach der Einbehaltung hält Aldag weiterhin direkt 5.354.656 MPW-Aktien. Es waren keine Derivate beteiligt, und es gab keine Käufe oder Verkäufe am offenen Markt. Die Meldung signalisiert keine Änderung in Aldags Gesamtbesitzstrategie oder in den Fundamentaldaten des Unternehmens.

  • Transaktionstyp: Code F (steuerliche Einbehaltung, kein freiwilliger Verkauf)
  • Einbehaltene Aktien: 117.161 (ca. 2,2 % von Aldags Bestand nach der Transaktion)
  • Verbleibende Direktbestände: 5.354.656 Aktien
  • Keine neuen Optionen, Warrants oder Derivate gemeldet

Die Maßnahme ist administrativ und wird aus Marktperspektive allgemein als neutral eingestuft.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine tax-withholding; CEO still holds 5.35 M shares – no material bullish or bearish signal.

Code F transactions are mechanically triggered by restricted-stock vesting. They do not represent discretionary selling pressure and typically have little valuation impact. The 117 k shares withheld equal roughly 0.02 % of MPW’s 594 M basic shares outstanding, an immaterial float change. Aldag’s sizeable remaining stake underscores continued alignment with shareholders. Overall, the filing is neutral and not impactful for near-term price action.

Medical Properties Trust, Inc. (MPW) – Comunicazione Form 4, 8 luglio 2025

Il Presidente, Amministratore Delegato ed Executive Chairman Edward K. Aldag Jr. ha riportato una transazione di routine, non effettuata sul mercato aperto, contrassegnata con il codice “F”, che indica il ritenuta fiscale sulla maturazione di azioni vincolate. La società ha trattenuto 117.161 azioni ordinarie a un prezzo implicito di 4,35 $ per azione per coprire le imposte dovute. Dopo questa ritenuta, Aldag detiene direttamente ancora 5.354.656 azioni MPW. Non sono stati coinvolti strumenti derivati e non ci sono stati acquisti o vendite sul mercato aperto. La comunicazione non indica cambiamenti nella strategia complessiva di possesso di Aldag né nei fondamentali della società.

  • Tipo di transazione: Codice F (ritenuta fiscale, non vendita volontaria)
  • Azioni trattenute: 117.161 (circa il 2,2% delle partecipazioni di Aldag dopo la transazione)
  • Detenzioni dirette residue: 5.354.656 azioni
  • Nessuna nuova opzione, warrant o derivato dichiarato

L’operazione è di natura amministrativa ed è generalmente considerata neutrale in termini di impatto sul mercato.

Medical Properties Trust, Inc. (MPW) – Presentación Formulario 4, 8 de julio de 2025

El Presidente, Director General y CEO Edward K. Aldag Jr. reportó una transacción rutinaria, no realizada en el mercado abierto, codificada como “F”, que indica retención fiscal sobre la consolidación de acciones restringidas. La empresa retuvo 117,161 acciones comunes a un precio implícito de $4.35 por acción para cubrir los impuestos legales. Tras la retención, Aldag continúa poseyendo directamente 5,354,656 acciones de MPW. No se involucraron valores derivados, ni hubo compras o ventas en el mercado abierto. La presentación no señala un cambio en la estrategia general de propiedad de Aldag ni en los fundamentos de la empresa.

  • Tipo de transacción: Código F (retención fiscal, no venta voluntaria)
  • Acciones retenidas: 117,161 (≈2.2 % de las participaciones de Aldag tras la transacción)
  • Participaciones directas restantes: 5,354,656 acciones
  • No se revelaron nuevas opciones, warrants ni derivados

La acción es de carácter administrativo y generalmente se considera neutral en cuanto a su impacto en el mercado.

Medical Properties Trust, Inc. (MPW) – 2025년 7월 8일 Form 4 제출

회장 겸 사장 및 CEO인 Edward K. Aldag Jr.는 “F” 코드로 분류된 일상적인 비공개시장 거래를 보고했으며, 이는 제한 주식의 취득에 따른 세금 원천징수를 의미합니다. 회사는 법정 세금을 충당하기 위해 주당 4.35달러의 암시 가격으로 117,161 보통주를 원천징수했습니다. 원천징수 후 Aldag는 직접적으로 5,354,656 MPW 주식을 계속 보유하고 있습니다. 파생 증권은 포함되지 않았으며, 공개 시장에서의 매매도 없었습니다. 이번 제출은 Aldag의 전체 보유 전략이나 회사의 기본적 상황에 변화를 의미하지 않습니다.

  • 거래 유형: 코드 F (세금 원천징수, 자발적 매도가 아님)
  • 원천징수된 주식 수: 117,161주 (거래 후 Aldag 보유 주식의 약 2.2%)
  • 남은 직접 보유 주식: 5,354,656주
  • 새로운 옵션, 워런트 또는 파생상품 없음

이번 조치는 행정적인 성격이며 시장 영향 측면에서 중립적으로 평가됩니다.

Medical Properties Trust, Inc. (MPW) – Déclaration Formulaire 4, 8 juillet 2025

Le Président, Directeur Général et CEO Edward K. Aldag Jr. a signalé une transaction de routine, non réalisée sur le marché ouvert, codée « F », indiquant une retenue fiscale sur l’acquisition d’actions restreintes. La société a retenu 117 161 actions ordinaires à un prix implicite de 4,35 $ par action pour couvrir les impôts légaux. Après cette retenue, Aldag détient directement 5 354 656 actions MPW. Aucun titre dérivé n’a été impliqué, et aucune opération sur le marché ouvert n’a eu lieu. Cette déclaration ne traduit aucun changement dans la stratégie globale de détention d’Aldag ni dans les fondamentaux de la société.

  • Type de transaction : Code F (retenue fiscale, pas une vente volontaire)
  • Actions retenues : 117 161 (environ 2,2 % des avoirs d’Aldag après la transaction)
  • Actions détenues directement restantes : 5 354 656
  • Aucune nouvelle option, warrant ou dérivé déclaré

L’opération est de nature administrative et est généralement considérée comme neutre en termes d’impact sur le marché.

Medical Properties Trust, Inc. (MPW) – Form 4 Einreichung, 8. Juli 2025

Der Vorsitzende, Präsident und CEO Edward K. Aldag Jr. meldete eine routinemäßige, nicht am offenen Markt durchgeführte Transaktion mit dem Code „F“, was auf eine steuerliche Einbehaltung bei der Freigabe von eingeschränkten Aktien hinweist. Das Unternehmen behielt 117.161 Stammaktien zu einem impliziten Preis von 4,35 $ pro Aktie ein, um die gesetzlichen Steuern zu decken. Nach der Einbehaltung hält Aldag weiterhin direkt 5.354.656 MPW-Aktien. Es waren keine Derivate beteiligt, und es gab keine Käufe oder Verkäufe am offenen Markt. Die Meldung signalisiert keine Änderung in Aldags Gesamtbesitzstrategie oder in den Fundamentaldaten des Unternehmens.

  • Transaktionstyp: Code F (steuerliche Einbehaltung, kein freiwilliger Verkauf)
  • Einbehaltene Aktien: 117.161 (ca. 2,2 % von Aldags Bestand nach der Transaktion)
  • Verbleibende Direktbestände: 5.354.656 Aktien
  • Keine neuen Optionen, Warrants oder Derivate gemeldet

Die Maßnahme ist administrativ und wird aus Marktperspektive allgemein als neutral eingestuft.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Portal Larry H

(Last) (First) (Middle)
1000 URBAN CENTER DRIVE
SUITE 501

(Street)
BIRMINGHAM AL 35242

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MEDICAL PROPERTIES TRUST INC [ MPW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Senior Advisor to the CEO
3. Date of Earliest Transaction (Month/Day/Year)
07/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 07/08/2025 F 1,571(1) D $4.35 403,846 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.
W. Zachary Riddle, by power of attorney 07/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MPW CEO Edward Aldag report in the 8 Jul 2025 Form 4?

He reported 117,161 MPW shares withheld for taxes upon restricted-stock vesting; no open-market sale took place.

How many MPW shares does the CEO own after the transaction?

Edward Aldag directly owns 5,354,656 common shares following the withholding.

What does transaction code “F” mean in a Form 4?

Code F denotes shares withheld by the issuer to satisfy tax obligations when restricted stock vests; it is not a discretionary sale.

Were any derivative securities involved in this MPW Form 4 filing?

No. The filing shows no options, warrants, or other derivatives acquired or disposed.

Is the Form 4 likely to impact MPW’s stock price?

The event is administrative and not considered material; it is unlikely to affect MPW’s valuation.
Medical Prop

NYSE:MPW

MPW Rankings

MPW Latest News

MPW Latest SEC Filings

MPW Stock Data

2.63B
496.82M
17.28%
62.69%
30.7%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
BIRMINGHAM